[Elsevier] A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China

Almarfadi Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-09-26 18:08

Reward20points

journal：Clinical Microbiology and Infection

Authors：Feng Sun; Yang Li; Yilin Zhang; Cui Cai; Yuanyuan Chen; Hengzhong Yi; Qianhong Wu; Yuan Qian; Hongying Yu; Yuanbo Lan; Jichan Shi; Ya Huang; Yungui Zhang; Shun Feng; Mingying Xiao; Jing Wang; Yiming Li; Zebao He; Haiqing Liu; Yena Zhang; Yu Chen; Yong Zhou; Jinlan Li; Bin Chen; Lin Xu; Jianfeng Luo; Yajiao Xing; Xiaolin Wei; Yanlin Zhao; Wenhong Zhang

Published date：2026-3-

DOI：10.1016/j.cmi.2025.11.015

PDF link：https://www.sciencedirect.com/sc ... 198743X25005701/pdf

Article link：https://doi.org/10.1016/j.cmi.2025.11.015

Article Source：Elsevier BV。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

Almarfadi Lv.3

Intermediate member

post
reply
points
450

[Elsevier] A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China